Bacteriophages, Antibiotics and Probiotics: Exploring the Microbial Battlefield of Colorectal Cancer
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cristian Constantin Volovat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Probiotics, Bacteriophages, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC), a prevalent malignancy, is a significant global health concern. The intricate interplay of genetic mutations, inflammatory processes, and environmental factors underscores the complexity of CRC’s etiology. The human gut harbors a diverse microbial community that plays a key role in maintaining homeostasis and influencing various aspects of host physiology. Perturbations in the gut microbiome (GM) composition and function have been implicated in CRC carcinogenesis. This bidirectional relationship involves microbial contributions to inflammation, DNA damage, and immune modulation, shaping the tumor microenvironment (TME). Bacteriophages, viruses that infect bacteria, contribute to the microbiome’s diversity and function by influencing bacterial abundance and composition. These phages can impact host–microbiome interactions, potentially influencing CRC risk. Furthermore, they can be manipulated to transport targeted medication, without being metabolized. Antibiotics exert selective pressures on the gut microbiome, leading to shifts in bacterial populations and potential dysbiosis. Probiotics can modulate the composition and activity of the GM and could be considered adjunctive therapy in the treatment of CRC. Understanding the intricate balance between bacteriophages, antibiotics–probiotics, and the GM is essential for comprehending CRC etiology and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Center of Oncology Euroclinic, 700106 Iasi, Romania.
- Department of Medical Oncology-Radiotherapy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.
- Department of Medical Oncology, Al. Trestioreanu Institute of Oncology, 022328 Bucharest, Romania.
- Department of Oncology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
ORCID-Profile: Mihai Andrei Cosovanu, Iolanda Georgiana Augustin
Zitieren
APA
Volovat, C. C., Cosovanu, M. A., Ostafe, M. R., Augustin, I. G., Volovat, C., Georgescu, B., & Volovat, S. R. (2025). Bacteriophages, Antibiotics and Probiotics: Exploring the Microbial Battlefield of Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167837
Vancouver
Volovat CC, Cosovanu MA, Ostafe MR, Augustin IG, Volovat C, Georgescu B, et al. Bacteriophages, Antibiotics and Probiotics: Exploring the Microbial Battlefield of Colorectal Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167837
BibTeX
@article{Volovat2025,
author = {Volovat, Cristian Constantin and Cosovanu, Mihai Andrei and Ostafe, Madalina-Raluca and Augustin, Iolanda Georgiana and Volovat, Constantin and Georgescu, Bogdan and Volovat, Simona Ruxandra},
title = {Bacteriophages, Antibiotics and Probiotics: Exploring the Microbial Battlefield of Colorectal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167837}
}
EUVIMED